跳至主要内容
临床试验/JPRN-UMIN000053224
JPRN-UMIN000053224招募中Unknown

Evaluation of the Efficacy and Safety of Basal-Bolus Insulin Therapy combined SGLT2 Inhibitors in Patients with Type 2 Diabetes Mellitus Hospitalized for Hyperglycemia; An open-label prospective randomized trial - Efficacy and Safety of Basal-Bolus Insulin Therapy with SGLT2 Inhibitors in Patients with Type 2 Diabetes Mellitus Hospitalized

Ichinomiynishi Hospital0 个研究点目标入组 36 人开始时间: 2023年12月26日最近更新:

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 90years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Type 1 diabetes mellitus 2) Frequent insulin injections 3) Pregnancy 4) On SGLT2 inhibitors (washout for at least 1 week is acceptable) 5) DPP4 inhibitor in once-weekly formulation 6) Once-weekly GLP-1RA 7) Undergoing chemotherapy 8) DKA or history of DKA 9) Hyperglycemic coma 10)High-dose steroids (>10 mg PSL equivalent)

研究者

发起方
Ichinomiynishi Hospital

相似试验